SNX vs. NVO
SNX (TD SYNNEX Corporation) and NVO (Novo Nordisk A/S) are both stocks. SNX operates in Information Technology Services (Technology), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SNX returned 18.83%/yr vs 8.21%/yr for NVO. At a 0.22 correlation, their price movements are largely independent.
Performance
SNX vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNX achieves a 68.21% return, which is significantly higher than NVO's 0.24% return. Over the past 10 years, SNX has outperformed NVO with an annualized return of 18.83%, while NVO has yielded a comparatively lower 8.21% annualized return.
SNX
- 1D
- -0.08%
- 1M
- -10.45%
- 6M
- 68.14%
- YTD
- 68.21%
- 1Y
- 78.73%
- 3Y*
- 38.79%
- 5Y*
- 18.09%
- 10Y*
- 18.83%
NVO
- 1D
- -0.40%
- 1M
- 12.31%
- 6M
- -14.80%
- YTD
- 0.24%
- 1Y
- -25.17%
- 3Y*
- -12.72%
- 5Y*
- 4.73%
- 10Y*
- 8.21%
SNX vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNX TD SYNNEX Corporation | 68.21% | 29.82% | 10.55% | 15.25% | -16.11% | 41.48% | 26.81% | 61.74% | -39.71% | 13.33% |
NVO Novo Nordisk A/S | 0.24% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between SNX and NVO is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Nov 25, 2003 | 0.22 |
Fundamentals
SNX:
$20.09B
NVO:
$218.99B
SNX:
$18.75
NVO:
DKK 27.42
SNX:
13.40
NVO:
11.79
SNX:
1.03
NVO:
0.51
SNX:
0.29
NVO:
4.39
SNX:
2.25
NVO:
7.08
SNX:
$69.77B
NVO:
DKK 327.80B
SNX:
$4.76B
NVO:
DKK 268.30B
SNX:
$1.66B
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNX vs. NVO — Risk / Return Rank
SNX
NVO
SNX vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TD SYNNEX Corporation (SNX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNX | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.04 | ||
| Sortino ratioReturn per unit of downside risk | +3.69 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 0.94 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 4.22 | -0.51 | +4.73 |
| Martin ratioReturn relative to average drawdown | 12.55 | -0.80 | +13.35 |
Loading charts...
Drawdowns
SNX vs. NVO - Drawdown Comparison
The maximum SNX drawdown since its inception was -67.27%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for SNX and NVO.
Loading charts...
Drawdown Indicators
| SNX | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.27% | -74.70% | +7.43% |
Max Drawdown (1Y)Largest decline over 1 year | -18.77% | -49.17% | +30.40% |
Max Drawdown (3Y)Largest decline over 3 years | -33.78% | -74.70% | +40.92% |
Max Drawdown (5Y)Largest decline over 5 years | -36.52% | -74.70% | +38.18% |
Max Drawdown (10Y)Largest decline over 10 years | -55.94% | -74.70% | +18.76% |
Current DrawdownCurrent decline from peak | -13.38% | -64.19% | +50.81% |
Average DrawdownAverage peak-to-trough decline | -15.32% | -17.87% | +2.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.29% | 31.54% | -25.25% |
Volatility
SNX vs. NVO - Volatility Comparison
TD SYNNEX Corporation (SNX) has a higher volatility of 11.57% compared to Novo Nordisk A/S (NVO) at 8.73%. This indicates that SNX's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNX | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.57% | 8.73% | +2.84% |
Volatility (6M)Calculated over the trailing 6-month period | 25.69% | 37.44% | -11.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.14% | 51.74% | -20.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.74% | 38.53% | -8.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.66% | 32.60% | +2.06% |
Dividends
SNX vs. NVO - Dividend Comparison
SNX's dividend yield for the trailing twelve months is around 0.56%, less than NVO's 3.66% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.66% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
SNX TD SYNNEX Corporation | 0.56% | 1.17% | 1.36% | 1.30% | 1.27% | 0.70% | 0.25% | 1.16% | 1.73% | 0.77% | 0.70% | 0.64% |
Financials
SNX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between TD SYNNEX Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNX vs. NVO - Profitability Comparison
SNX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, TD SYNNEX Corporation reported a gross profit of 1.34B and revenue of 19.57B. Therefore, the gross margin over that period was 6.8%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
SNX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, TD SYNNEX Corporation reported an operating income of 519.36M and revenue of 19.57B, resulting in an operating margin of 2.7%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
SNX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, TD SYNNEX Corporation reported a net income of 716.76M and revenue of 19.57B, resulting in a net margin of 3.7%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
SNX and NVO have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SNX has higher volatility (11.57%) compared to NVO (8.73%). In terms of maximum drawdown, SNX dropped -67.27% vs NVO's -74.70%.
SNX currently has the higher Sharpe Ratio (2.55 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNX and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer